🔥🐔 BizChicken 🐔🔥

Companies Similar to BioCardia, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Anixa Biosciences, Inc.

Anixa Biosciences, Inc. logo
Market Cap: Low
Employees: Lowest

Chimeric Endocrine Receptor T-cell Technology, Anti-Viral Drug Candidates, Vaccines

Anixa Biosciences, Inc. is a biotechnology company focused on developing therapies and vaccines for oncology and infectious diseases, including novel CAR-T technologies for ovarian cancer and vaccines for breast and ovarian cancer.

Tags: CAR-T therapy, COVID-19, anti-viral drugs, biotechnology, infectious diseases, oncology, vaccine development

Symbol: ANIX

Recent Price: $2.50

Industry: Biotechnology

CEO: Dr. Amit Kumar Ph.D.

Sector: Healthcare

Employees: 4

Address: 3150 Almaden Expressway, San Jose, CA 95118

Phone: 408 708 9808

Last updated: 2024-12-31

BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc. logo
Market Cap: Lowest
Employees: Lowest

BRTX-100

Bio Restorative Therapies, Inc., a life sciences company, focuses on developing regenerative medicine products and therapies primarily involving adult stem cells to treat disc/spine disease and metabolic disorders.

Tags: biotechnology, cell therapy, disc/spine disease, metabolic disorders, regenerative medicine, stem cells

Symbol: BRTX

Recent Price: $1.44

Industry: Biotechnology

CEO: Mr. Lance Alstodt

Sector: Healthcare

Employees: 11

Address: 40 Marcus Drive, Melville, NY 11747

Phone: 631 760 8100

Last updated: 2024-12-31

CVRx, Inc.

CVRx, Inc. logo
Market Cap: Low
Employees: Low

Barostim

CVRx, Inc. is a commercial-stage medical device company focusing on developing, manufacturing, and commercializing neuromodulation solutions for cardiovascular diseases, offering Barostim for heart failure patients.

Tags: Barostim, cardiovascular, heart failure, medical device, neuromodulation

Symbol: CVRX

Recent Price: $12.77

Industry: Medical - Devices

CEO: Mr. Kevin Hykes

Sector: Healthcare

Employees: 200

Address: 9201 West Broadway Avenue, Minneapolis, MN 55445

Phone: 763 416 2840

Last updated: 2024-12-31

ImmunityBio, Inc.

ImmunityBio, Inc. logo
Market Cap: High
Employees: Medium

Therapies and Vaccines

Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.

Tags: biotechnology, cancer, cell therapy, immunotherapy, infectious diseases, vaccines

Symbol: IBRX

Recent Price: $2.68

Industry: Biotechnology

CEO: Mr. Richard Gerald Adcock

Sector: Healthcare

Employees: 622

Address: 3530 John Hopkins Court, San Diego, CA 92121

Phone: 858 633 0300

Last updated: 2024-12-31

Mustang Bio, Inc.

Mustang Bio, Inc. logo
Market Cap: Lowest
Employees: Low

Gene and CAR T Cell Therapies

Mustang Bio, Inc. is a biopharmaceutical company specializing in cell and gene therapies for hematologic cancers, solid tumors, and rare genetic diseases. It focuses on developing gene therapy programs and CAR T cell therapies, including treatments for X-linked severe combined immunodeficiency and various types of cancer.

Tags: CAR T cell, biopharmaceutical, gene therapy, genetic diseases, hematologic cancers, solid tumors

Symbol: MBIO

Recent Price: $0.19

Industry: Biotechnology

CEO: Dr. Manuel Litchman M.D.

Sector: Healthcare

Employees: 80

Address: 377 Plantation Street, Worcester, MA 01605

Phone: 781 652 4500

Leadership

  • Manuel Litchman, M.D., President, Chief Executive Officer and Director
  • Greg Furrow, M.S., FRQA, Chief Quality Officer
  • James Murphy, B.A., Ad interim Chief Financial Officer
  • Michael S. Weiss, Chairman of the Board of Directors
  • Lindsay A. Rosenwald, M.D., Director
  • Adam J. Chill, Director
  • Neil Herskowitz, Director
  • Michael J. Zelefsky, M.D., Director
  • Mustang Bio, Inc., Company

Last updated: 2024-12-31

PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc. logo
Market Cap: Lowest
Employees: Lowest

Cell-in-a-Box

Pharma Cyte Biotech, Inc. is a biotechnology company focused on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites. Their therapies are based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology, used for treating various cancers and diabetes.

Tags: Cell-in-a-Box, biotechnology, cancer, cannabis plant, cellular therapies, diabetes, insulin-dependent diabetes, live cell encapsulation, pancreatic cancer

Symbol: PMCB

Recent Price: $1.55

Industry: Biotechnology

CEO: Mr. Joshua N. Silverman

Sector: Healthcare

Employees: 2

Address: 3960 Howard Hughes Parkway, Las Vegas, NV 89169

Phone: 917 595 2850

Leadership

  • Joshua N. Silverman, Independent Director
  • Dr. Michael M. Abecassis, Independent Director
  • Robert Weinstein, Director
  • Wayne R. Walker, Director
  • Jonathan L. Schechter, Independent Director
  • Dr. Abecassis, Director
  • Kenneth L. Waggoner, Independent Director
  • Daniel C. Farb, Independent Director
  • Daniel C. Allen, Independent Director
  • Jack E. Stover, Independent Director

Last updated: 2024-12-31

Pulse Biosciences, Inc.

Pulse Biosciences, Inc. logo
Market Cap: Medium
Employees: Lowest

Cell FX System

Pulse Biosciences, Inc. is a bioelectric medicine company that offers the Cell FX System, a platform using Nano-Pulse Stimulation technology to treat various medical conditions by targeting cells with electrical energy pulses.

Tags: Cell FX System, Nano-Pulse Stimulation, bioelectric medicine, healthcare technology

Symbol: PLSE

Recent Price: $17.66

Industry: Medical - Instruments & Supplies

CEO: Mr. Burke T. Barrett

Sector: Healthcare

Employees: 56

Address: 3957 Point Eden Way, Hayward, CA 94545

Phone: 510 906 4600

Last updated: 2024-12-31

Tenaya Therapeutics, Inc.

Tenaya Therapeutics, Inc. logo
Market Cap: Low
Employees: Low

TN-201, TN-301, TN-401

Tenaya Therapeutics, Inc. is a biotechnology company that discovers, develops, and delivers therapies for heart disease using cellular regeneration, gene therapy, and precision medicine platforms.

Tags: biotechnology, gene therapy, heart disease, precision medicine, therapeutics

Symbol: TNYA

Recent Price: $1.45

Industry: Biotechnology

CEO: Mr. Faraz Ali M.B.A.

Sector: Healthcare

Employees: 140

Address: 171 Oyster Point Boulevard, South San Francisco, CA 94080

Phone: 650 825 6900

Last updated: 2024-12-31

Arcellx, Inc.

Arcellx, Inc. logo
Market Cap: High
Employees: Low

CART-dd BCMA

Arcellx, Inc. is a clinical-stage biotechnology company dedicated to developing immunotherapies for cancer and other incurable diseases, with a focus on its lead product candidate, CART-dd BCMA, for treating relapsed or refractory multiple myeloma.

Tags: acute myeloid leukemia, biotechnology, cancer treatment, clinical-stage, immunotherapy, multiple myeloma, myelodysplastic syndrome

Symbol: ACLX

Recent Price: $78.35

Industry: Biotechnology

CEO: Mr. Rami Elghandour

Sector: Healthcare

Employees: 130

Address: 25 West Watkins Mill Road, Gaithersburg, MD 20878

Phone: 240 327 0603

Last updated: 2024-12-31

HeartBeam, Inc.

HeartBeam, Inc. logo
Market Cap: Lowest
Employees: Lowest

Heart Beam AIMIGo™

Heart Beam, Inc. is a medical technology company focused on telemedicine solutions for the detection and monitoring of cardiac disease. It offers a credit card-sized ECG device and a cloud-based diagnostic software system for remote patient monitoring.

Tags: ECG, cardiac monitoring, healthcare technology, remote patient monitoring, telemedicine

Symbol: BEAT

Recent Price: $2.16

Industry: Medical - Healthcare Information Services

CEO: Mr. Robert P. Eno

Sector: Healthcare

Employees: 15

Address: 2118 Walsh Avenue, Santa Clara, CA 95050

Phone: 408 899 4443

Last updated: 2024-12-31

Biora Therapeutics, Inc.

Biora Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

oral biotherapeutics

Biora Therapeutics, Inc., a biotechnology company, focuses on developing oral biotherapeutics using ingestible smart capsules for targeted delivery in the gastrointestinal tract and needle-free delivery into the intestinal mucosa.

Tags: GI diseases, biotechnology, diagnostics, inflammatory bowel diseases, oral biotherapeutics, systemic uptake

Symbol: BIOR

Recent Price: $0.22

Industry: Biotechnology

CEO: Mr. Aditya P. Mohanty M.B.A.

Sector: Healthcare

Employees: 58

Address: 4330 La Jolla Village Drive, San Diego, CA 92122

Phone: 855 293 2639

Leadership

  • Adi Mohanty, MBA, Chief Executive Officer & Board Member
  • Eric d’Esparbes, Chief Financial Officer
  • Robyn Hatton, Head of Human Resources
  • Ariella Kelman, MD, Chief Medical Officer
  • James Knight, MBA, Head of Business Development
  • Clarke Neumann, JD, General Counsel and Secretary
  • Paul Shabram, MBA, Head of Technical Operations
  • Sharat Singh, PhD, Head of Research
  • Maria (Mimi) Villanueva CPMI, PPMC, Vice President, Product Development Operations & Program Management
  • Jeffrey Alter, MBA, Board Chair
  • Jeffrey Ferrell, Board Member
  • Jill Howe, Board Member
  • Brian Kotzin, MD, Board Member
  • Lynne Powell, MBA, Board Member
  • Bruce Sands, MD, MS, Advisory Board Chair
  • Geert D’Haens, MD, PhD, Advisory Board Member
  • Brian Feagan, MD, FRCPC, Advisory Board Member
  • Séverine Vermeire, MD, PhD, Advisory Board Member
  • Satish Rao, MD, PhD, Advisory Board Chair
  • William Chey, MD, Advisory Board Member
  • Anthony Lembo, MD, Advisory Board Member
  • Mark Pimentel, MD, Advisory Board Member

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. logo
Market Cap: Lowest
Employees: Lowest

Epi+Gen CHD

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease, offering products like Epi+Gen CHD to assess risk and personalize care using AI and precision epigenetics.

Tags: AI, Cardiovascular Disease, Clinical Tests, Epigenetics, Healthcare, Precision Medicine

Symbol: CDIO

Recent Price: $0.82

Industry: Biotechnology

CEO: Dr. Meeshanthini V. Dogan Ph.D.

Sector: Healthcare

Employees: 7

Address: 400 N Aberdeen St, Chicago, IL 60642

Phone: 855 226 9991

Last updated: 2024-12-31

Celularity Inc.

Celularity Inc. logo
Market Cap: Lowest
Employees: Low

CYCART-19, CYNK-001, CYNK-101, APPL-001, PDA-002

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and Bio Banking.

Tags: biotechnology, cancer, cell therapies, immune diseases, infectious diseases, placental-derived

Symbol: CELU

Recent Price: $2.05

Industry: Biotechnology

CEO: Dr. Robert Joseph Hariri M.D., Ph.D.

Sector: Healthcare

Employees: 120

Address: 170 Park Avenue, Florham Park, NJ 07932

Phone: 908 768 2170

Leadership

  • Robert J. Hariri, M.D., Ph.D., Chairperson, Founder, and CEO
  • David Beers, CFA, Chief Financial Officer
  • Stephen Brigido, DPM, President, Degenerative Diseases
  • John Haines, Global Manager and Chief Administrative Officer
  • K. Harold Fletcher, Esq., General Counsel & Chief Compliance Officer
  • John Colerangle, DVM, Ph.D., Regulatory Affairs
  • Anna Gosiewska, Ph.D., R&D, Degenerative Diseases
  • Sharmila Koppisetti, M.D., Clinical Development Immunology & Drug Safety
  • Carmine Palummo, Corporate Operations
  • Tim Wilk, Technical Operations
  • Robert J. Hariri, M.D., Ph.D, Chairperson, Founder & CEO
  • Peter Diamandis, M.D., Director
  • Dean Kehler, Director
  • Geoffrey Shiu Fei Ling, M.D., Ph.D., Director
  • Diane Parks, Director

Last updated: 2024-12-31

Caribou Biosciences, Inc.

Caribou Biosciences, Inc. logo
Market Cap: Low
Employees: Low

CB-010, CB-011, CB-012, CB-020

Caribou Biosciences is a clinical-stage biopharmaceutical company focused on developing genome-edited allogeneic cell therapies for treating hematologic malignancies and solid tumors, with several product candidates in clinical trials.

Tags: CAR-NK, CAR-T, biopharmaceutical, cell therapies, clinical-stage, genome-edited therapies, hematologic malignancies, solid tumors

Symbol: CRBU

Recent Price: $1.61

Industry: Biotechnology

CEO: Dr. Rachel E. Haurwitz Ph.D.

Sector: Healthcare

Employees: 158

Address: 2929 7th Street, Berkeley, CA 94710

Phone: 510 982 6030

Last updated: 2024-12-31

Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. logo
Market Cap: Low
Employees: Lowest

Back Beat Cardiac Neuromodulation Therapy (CNT), Virtue Sirolimus Angio Infusion Balloon (SAB)

Orchestra Bio Med Holdings, Inc. is a biomedical innovation company specializing in treatments for hypertension and atherosclerotic artery disease, with strategic collaborations with Medtronic and Terumo Corporation.

Tags: atherosclerotic artery disease, biomedical, hypertension, innovation, minimally invasive surgery, strategic partnership

Symbol: OBIO

Recent Price: $4.25

Industry: Biotechnology

CEO: Mr. David P. Hochman

Sector: Healthcare

Employees: 56

Address: 150 Union Square Drive, New Hope, PA 18938

Phone: 215 862 5797

Last updated: 2024-12-31

BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. logo
Market Cap: High
Employees: Medium

AG10, BBP-265, BBP-831, BBP-631, Encaleret

Bridge Bio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases, with a pipeline of 30 programs including candidates like AG10, BBP-265, and others in various stages of clinical trials.

Tags: biopharmaceuticals, clinical trials, drug development, genetic diseases

Symbol: BBIO

Recent Price: $27.32

Industry: Biotechnology

CEO: Dr. Neil Kumar Ph.D.

Sector: Healthcare

Employees: 550

Address: 421 Kipling Street, Palo Alto, CA 94301

Phone: 650 391 9740

Last updated: 2024-12-31

BioCardia, Inc.

BioCardia, Inc. logo
Market Cap: Lowest
Employees: Lowest

Cardi AMP Cell Therapy System

Bio Cardia, Inc. is a clinical-stage regenerative medicine company focused on developing cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Their lead candidate, the Cardi AMP Cell Therapy System, targets heart failure and myocardial ischemia, with additional developments in cell delivery and therapeutic platforms.

Tags: cardiovascular, cell therapy, clinical-stage, pulmonary diseases, regenerative medicine

Symbol: BCDA

Recent Price: $2.15

Industry: Biotechnology

CEO: Dr. Peter A. Altman Ph.D.

Sector: Healthcare

Employees: 16

Address: 320 Soquel Way, Sunnyvale, CA 94085

Phone: 650 226 0120

Leadership

  • David McClung, CFO
  • Edward Gillis, Sr. VP of Devices
  • Debby Holmes-Higgin, MPH, VP of Clinical
  • Andrew Scott Blank, Chairman
  • Simon H. Stertzer, M.D., Professor of Medicine, Emeritus
  • Jay M. Moyes, Director
  • Bill Facteau, President and Chief Executive Officer
  • Richard Krasno, Ph.D., Director
  • Jim Allen, Chief Executive Officer and President
  • Peter Altman, Ph.D., President and Chief Executive Officer

Last updated: 2024-12-31

Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc. logo
Market Cap: Lowest
Employees: Lowest

Imm Celz

Creative Medical Technology Holdings, Inc. is a biotechnology company focusing on using adult stem cell treatments for immunology, urology, orthopedics, and neurology, offering solutions like Caver Stem, Fem Celz, Stem Spine, Imm Celz, and Ova Stem.

Tags: biotechnology, immunology, neurology, orthopedics, stem cell treatments, urology

Symbol: CELZ

Recent Price: $2.34

Industry: Biotechnology

CEO: Mr. Timothy Warbington

Sector: Healthcare

Employees: 4

Address: 211 East Osborn Road, Phoenix, AZ 85012

Phone: 480 399 2822

Last updated: 2024-12-31

ProKidney Corp.

ProKidney Corp. logo
Market Cap: Medium
Employees: Low

Renal Autologous Cell Therapy

Pro Kidney Corp. is a clinical-stage biotechnology company focused on developing cellular therapy candidates, including Renal Autologous Cell Therapy, for the treatment of diabetic kidney disease and congenital anomalies of the kidney and urinary tract.

Tags: Phase III development, biotechnology, cellular therapy, clinical trials, diabetic kidney disease

Symbol: PROK

Recent Price: $1.75

Industry: Biotechnology

CEO: Dr. Bruce Culleton M.D.

Sector: Healthcare

Employees: 163

Address: 2000 Frontis Plaza Blvd., Winston-Salem, NC 27103

Phone: 336 999 7028

Leadership

  • Bruce Culleton, MD, Chief Executive Officer
  • James Coulston, CPA, Chief Financial Officer
  • Todd C. Girolamo, JD, MBA, Chief Legal Officer and Secretary
  • Nikhil Pereira-Kamath, Chief Business Officer
  • Darin J. Weber, PhD, Chief Regulatory Officer
  • Carla Poulson, Chief People Officer
  • Ulrich Ernst, PhD, EVP, Technical Operations
  • Emily Butler, PhD, SVP, Biometrics
  • Joseph Stavas, MD, MPH, SVP, Interventional Procedures and Patient Safety
  • Lucio Tozzi, SVP, Global Clinical Operations
  • Richard Williams, SVP, Information Technology

Last updated: 2024-12-31